Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The number that made headlines: 45.3% of people on the 12 mg dose lost 30% or more of their body weight territory previously seen mostly after weight-loss surgery, and the highest share ever reported for an anti-obesity drug
These medications provide strong support while patients focus on improving their diet and exercise routines." Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality
No flavor, no yucky taste
This consultation assesses your BMI, medical history, and weight goals
The TRIUMPH-4 trial showed that retatrutide at 12mg reduced: Systolic blood pressure: 14.0 mmHg reduction Non-HDL cholesterol: clinically meaningful improvement High-sensitivity C-reactive protein: significant reduction (a marker of systemic inflammation) Triglycerides: substantial decrease Tirzepatide produces similar cardiovascular improvements, with well-documented reductions in blood pressure, triglycerides, and inflammatory markers across the SURMOUNT and SURPASS programs
Risk factors for pancreatic cancer include advancing age, smoking, chronic pancreatitis (not typically acute pancreatitis), family history, obesity, and diabetes itself
US$ 22.95
US$ 22.60
US$ 28.34
US$ 25.30
US$ 29.81
US$ 25.61
US$ 27.80
